摘要
目的:小儿肺热咳喘口服液结合阿奇霉素治疗小儿肺炎支原体肺炎疗效观察,增加小儿肺炎支原体肺炎的治疗效果。方法:根据随机性原则选取小儿肺炎支原体肺炎患者66例,将66例确诊为小儿肺炎支原体肺炎患者作为临床研究对象,随机盲法分为两组,对照组33例,观察组33例,对照组采取常规治疗肺炎支原体肺炎加上阿奇霉素进行治疗,观察在组采取在常规肺炎治疗方法的基础上增加小儿肺热咳喘口服液结合阿奇霉素治疗,治疗后观察两组患者治疗疗效,对比分析总结优异的治疗方法。结果:表1结果显示,对照治愈患儿13例(39.39%)远远少于观察组19例(57.56%),无效的患儿中对照组高达9例(27.27%),观察组仅2例(6.06%);两组患者比较差异有统计学意义(P<0.05)。结论:小儿肺炎支原体肺炎患者采取常规治疗以及小儿肺热咳喘口服液结合阿奇霉素进行治疗,疗效显著,且无明显不良反应,临床治疗可广泛应用。
Objective To observe the curative effect of azithromycin in treatment of mycoplasma pneumonia in children with infantile Feirekechuan oral liquid,increase the therapeutic effect of Mycoplasma pneumoniae pneumonia in children. Method According to the principle of random,66 patients of children with Mycoplasma pneumoniae pneumonia were selected,66 cases were diagnosed as Mycoplasma pneumonia patients as clinical research object,they were randomly divided into two groups,33 cases in the control group,33 cases in the observation group,the control group received routine treatment mycoplasma pneumonia with azithromycin treatment,observation group to increase in infantile Feirekechuan oral liquid combined with azithromycin treatment based on routine treatment of pneumonia,after treatment in two groups were observed the treatment effect,comparative analysis to summarize the treatment method of the excellent. Results Table 1 showed that the control group 13 cases were cured（39. 39%）,which was far less than the observation group of 19 cases（57. 56%）,invalid children in control group of 9cases（27. 27%）,the observation group only 2 cases（6. 06%）;the two groups were significantly different,with statistical significance（ P〈0. 05）. Conclusion The patients with mycoplasma pneumonia in children treated with conventional and infantile Feirekechuan oral liquid combined with azithromycin treatment,the curative effect is remarkable,and no obvious adverse reactions,can be widely used in clinical treatment.
出处
《吉林医学》
CAS
2017年第3期441-442,共2页
Jilin Medical Journal
